3-Iodothyronamine: Difference between revisions
m (Protected "3-Iodothyronamine": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
||
| Line 25: | Line 25: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
'''3-iodothyronamine''' (T<sub>1</sub>AM) is an [[endogenous]] [[thyronamine]]. T<sub>1</sub>AM is a high-affinity [[ligand]] for the [[trace amine-associated receptor]] TAAR1 (TAR1, TA1), a [[G protein-coupled receptor]].<ref>{{cite journal |author=Scanlan T, Suchland K, Hart M, Chiellini G, Huang Y, Kruzich P, Frascarelli S, Crossley D, Bunzow J, Ronca-Testoni S, Lin E, Hatton D, Zucchi R, Grandy D |title=3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone |journal=Nat. Med. |volume=10 |issue=6 |pages=638-42 |year=2004 |pmid=15146179}}</ref> | '''3-iodothyronamine''' (T<sub>1</sub>AM) is an [[endogenous]] [[thyronamine]]. T<sub>1</sub>AM is a high-affinity [[ligand]] for the [[trace amine-associated receptor]] TAAR1 (TAR1, TA1), a [[G protein-coupled receptor]].<ref>{{cite journal |author=Scanlan T, Suchland K, Hart M, Chiellini G, Huang Y, Kruzich P, Frascarelli S, Crossley D, Bunzow J, Ronca-Testoni S, Lin E, Hatton D, Zucchi R, Grandy D |title=3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone |journal=Nat. Med. |volume=10 |issue=6 |pages=638-42 |year=2004 |pmid=15146179}}</ref> | ||
| Line 46: | Line 46: | ||
[[Category:Iodinated tyrosine derivatives]] | [[Category:Iodinated tyrosine derivatives]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Latest revision as of 18:58, 8 August 2012
|
WikiDoc Resources for 3-Iodothyronamine |
|
Articles |
|---|
|
Most recent articles on 3-Iodothyronamine Most cited articles on 3-Iodothyronamine |
|
Media |
|
Powerpoint slides on 3-Iodothyronamine |
|
Evidence Based Medicine |
|
Cochrane Collaboration on 3-Iodothyronamine |
|
Clinical Trials |
|
Ongoing Trials on 3-Iodothyronamine at Clinical Trials.gov Trial results on 3-Iodothyronamine Clinical Trials on 3-Iodothyronamine at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on 3-Iodothyronamine NICE Guidance on 3-Iodothyronamine
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on 3-Iodothyronamine Discussion groups on 3-Iodothyronamine Patient Handouts on 3-Iodothyronamine Directions to Hospitals Treating 3-Iodothyronamine Risk calculators and risk factors for 3-Iodothyronamine
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for 3-Iodothyronamine |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
3-iodothyronamine (T1AM) is an endogenous thyronamine. T1AM is a high-affinity ligand for the trace amine-associated receptor TAAR1 (TAR1, TA1), a G protein-coupled receptor.[1]
[2] In rodents, T1AM causes a rapid drop in body temperature when injected.
T1AM may be part of a signaling pathway to modulate cardiac function as the compound can induce negative inotropic effects and decrease cardiac output.[3]
See also
External links
- 3-iodothyronamine at the US National Library of Medicine Medical Subject Headings (MeSH)
References
- ↑ Scanlan T, Suchland K, Hart M, Chiellini G, Huang Y, Kruzich P, Frascarelli S, Crossley D, Bunzow J, Ronca-Testoni S, Lin E, Hatton D, Zucchi R, Grandy D (2004). "3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone". Nat. Med. 10 (6): 638–42. PMID 15146179.
- ↑ Hart M, Suchland K, Miyakawa M, Bunzow J, Grandy D, Scanlan T (2006). "Trace amine-associated receptor agonists: synthesis and evaluation of thyronamines and related analogues". J. Med. Chem. 49 (3): 1101–12. PMID 16451074.
- ↑ Chiellini G, Frascarelli S, Ghelardoni S, Carnicelli V, Tobias SC, Debarber A, Brogioni S, Ronca-Testoni S, Cerbai E, Grandy DK, Scanlan TS, Zucchi R. (2007). "Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function". PMID 17284482.